Skip Nav Destination
            
    
            
 
    
    
        
            
                
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                     
    
                     
    
                    
        
        
     
    
                    
                    
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
        
        Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
        
        A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
        
        Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
    
        
    
    
    
            
        
            
    
        
        
    
             
            
             
            
             
        
    
 
    
    
 
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
Table of Contents
BLOOD ADVANCES TALK
DRUG ADVANCES
EXCEPTIONAL CASE REPORTS
STIMULUS REPORTS
Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia
            Elisavet Chartomatsidou,Stavroula Ntoufa,Konstantia Kotta,Alessandra Rovida,Maria Anna Akritidou,Daniela Belloni,Elisabetta Ferrero,Theoni Trangas,Niki Stavroyianni,Achilles Anagnostopoulos,Richard Rosenquist,Paolo Ghia,Nikos Papakonstantinou,Kostas Stamatopoulos
            
        
    
            REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
        
        Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Steven E. Coutre,John C. Byrd,Peter Hillmen,Jacqueline C. Barrientos,Paul M. Barr,Stephen Devereux,Tadeusz Robak,Thomas J. Kipps,Anna Schuh,Carol Moreno,Richard R. Furman,Jan A. Burger,Michael O’Dwyer,Paolo Ghia,Rudolph Valentino,Stephen Chang,James P. Dean,Danelle F. James,Susan M. O’Brien
            
        
    
            
        
        CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            M. O’Dwyer,R. Henderson,S. D. Naicker,M. R. Cahill,P. Murphy,V. Mykytiv,J. Quinn,C. McEllistrim,J. Krawczyk,J. Walsh,E. Lenihan,T. Kenny,A. Hernando,G. Hirakata,I. Parker,E. Kinsella,G. Gannon,A. Natoni,K. Lynch,A. E. Ryan
            
        
    
            IMMUNOBIOLOGY AND IMMUNOTHERAPY
MYELOID NEOPLASIA
        
        A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Leylah M. Drusbosky,Neeraj Kumar Singh,Kimberly E. Hawkins,Cesia Salan,Madeleine Turcotte,Elizabeth A. Wise,Amy Meacham,Vindhya Vijay,Glenda G. Anderson,Charlie C. Kim,Saumya Radhakrishnan,Yashaswini Ullal,Anay Talawdekar,Huzaifa Sikora,Prashant Nair,Arati Khanna-Gupta,Taher Abbasi,Shireen Vali,Subharup Guha,Nosha Farhadfar,Hemant S. Murthy,Biljana N. Horn,Helen L. Leather,Paul Castillo,Caitlin Tucker,Christina Cline,Leslie Pettiford,Jatinder K. Lamba,Jan S. Moreb,Randy A. Brown,Maxim Norkin,John W. Hiemenz,Jack W. Hsu,William B. Slayton,John R. Wingard,Christopher R. Cogle
            
        
    
            SYSTEMATIC REVIEW
THROMBOSIS AND HEMOSTASIS
Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate
            Johanna Zannoni,Natacha Mauz,Landry Seyve,Mathieu Meunier,Karin Pernet-Gallay,Julie Brault,Claire Jouzier,David Laurin,Mylène Pezet,Martine Pernollet,Jean-Yves Cahn,Fabrice Cognasse,Benoît Polack,Sophie Park
            
        
    
            TRANSPLANTATION
        
        Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Armin Rashidi,Mehdi Hamadani,Mei-Jie Zhang,Hai-Lin Wang,Hisham Abdel-Azim,Mahmoud Aljurf,Amer Assal,Ashish Bajel,Asad Bashey,Minoo Battiwalla,Amer M. Beitinjaneh,Nelli Bejanyan,Vijaya Raj Bhatt,Javier Bolaños-Meade,Michael Byrne,Jean-Yves Cahn,Mitchell Cairo,Stefan Ciurea,Edward Copelan,Corey Cutler,Andrew Daly,Miguel-Angel Diaz,Nosha Farhadfar,Robert P. Gale,Siddhartha Ganguly,Michael R. Grunwald,Theresa Hahn,Shahrukh Hashmi,Gerhard C. Hildebrandt,H. Kent Holland,Nasheed Hossain,Christopher G. Kanakry,Mohamed A. Kharfan-Dabaja,Nandita Khera,Yener Koc,Hillard M. Lazarus,Jong-Wook Lee,Johan Maertens,Rodrigo Martino,Joseph McGuirk,Reinhold Munker,Hemant S. Murthy,Ryotaro Nakamura,Sunita Nathan,Taiga Nishihori,Neil Palmisiano,Sagar Patel,Joseph Pidala,Rebecca Olin,Richard F. Olsson,Betul Oran,Olov Ringden,David Rizzieri,Jacob Rowe,Mary Lynn Savoie,Kirk R. Schultz,Sachiko Seo,Brian C. Shaffer,Anurag Singh,Melhem Solh,Keith Stockerl-Goldstein,Leo F. Verdonck,John Wagner,Edmund K. Waller,Marcos De Lima,Brenda M. Sandmaier,Mark Litzow,Dan Weisdorf,Rizwan Romee,Wael Saber
            
        
    
            
        
        Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Koen van Besien,Andrew Artz,Richard E. Champlin,Danielle Guarneri,Michael R. Bishop,Julianne Chen,Usama Gergis,Tsiporah Shore,Hongtao Liu,Gabriela Rondon,Sebastian A. Mayer,Samer A. Srour,Wendy Stock,Stefan O. Ciurea
            
        
    
            - 
        
            Cover Image
        
        Cover Image![issue cover]()  COVER FIGURE 
 Immunohistochemistry staining of a spleen in a mouse with T-cell lymphoma for CD30 after transplantation with CRISPR-modified hematopoietic stem cells. The image was taken at 600× magnification. See the article by Rajan et al.
- PDF Icon Front MatterFront Matter
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals
 
                    








